Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies. With more than 18,000 tissue samples and 1,800+ primary cell cultures. Cellipont expertise runs deep. Cellipont is driven to help its clients expand patient access to life-changing medicines through best-in-class development, analytical, and manufacturing capabilities.
Cellipont services include the creation of master and working cell bank...nks, analytical and process development, and manufacturing services for a range of clients from preclinical (research & development) to Phase I-II with near-term Phase III to commercialization capabilities.
Cellipont has experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches.
